SynthesisFrontiers in pharmacology2025
Effects of modified Soyo-san (Xiao-yao-san, Shoyo-san) combined with antidepressants on post-stroke depression and functional recovery: a systematic review and meta-analysis.
Synthesis in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Over one-third of stroke survivors experience Post Stroke Depression. Conventional antidepressants are effective but have adverse effects. Soyo-san is an herbal medicine used to treat neuropsychiatric diseases that may exert antidepressant effects with fewer adverse effects. However, there is insufficient evidence synthesizing existing Randomized Controlled Trials to provide comprehensive guidance on the effectiveness and safety of combination treatment with Soyo-san. Purpose: We evaluated the additional benefits and safety of combining Soyo-san with conventional antidepressants for treating Post Stroke Depression through a systematic review and meta-analysis. Methods: A comprehensive search of seven databases was conducted on October 10, 2024, followed by study selection and data extraction. Methodological quality was assessed using the Cochrane Collaboration's risk-of-bias tool, and evidence quality was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation method. Quantitative data synthesis and meta-analysis were conducted using RStudio, along with subgroup, sensitivity, and publication bias analyses. Results: The search retrieved 41 RCTs with 3,628 participants. Soyo-san had a significant effect on depression based on Hamilton Depression Scale score (MD: -4.01; 95% CI: -4.72, -3.30; Conclusion: Modified Soyo-san combined with antidepressants was associated with improvements in depressive symptoms and variety of functional outcomes, though the certainty of evidence is low to very low. Therefore, these findings should be interpreted with caution, and high-quality international trials are needed before firm conclusions can be drawn. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD42024510361, identifier CRD42024510361.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.